Nav: Home

Mitochondrial maps reveal new connections to poorly understood diseases

August 04, 2016

MADISON -- Mitochondria are the engines that drive cellular life, but these complex machines are vulnerable to a wide range of breakdowns, and hundreds of their component parts remain a functional mystery.

Dave Pagliarini, director of metabolism for the Morgridge Institute for Research and UW-Madison associate professor of biochemistry, is working to identify the more than 200 proteins associated with mitochondria that currently have no defined function. Completing this process will give science a complete map of mitochondrial function and help discover the origins of more than 150 poorly understood diseases associated with mitochondria.

New features of that map are taking shape today. Two related studies led by the Pagliarini Lab, published consecutively in today's (Aug. 4) issue of the journal Molecular Cell, identify functions for three little-known mitochondrial proteins that play either a direct or potential role in disease.

Mitochondria are tiny organelles that exist in all human cells except red blood cells and consume about 95 percent of oxygen people breathe in order to manufacture adenosine triphosphate (ATP), the chemical currency of the cell. Mitochondrial diseases strike about 1 in 4,000 people and there are currently no licensed therapies available, beyond treatments with vitamins and supplements.

"We began by trying to learn something about what these proteins do by understanding what other proteins they physically interact with," says Pagliarini. To do this, Pagliarini's group partnered with Josh Coon's laboratory, a group that specializes in mass spectrometry and protein analysis. Using the Coon Lab's cutting edge spectrometry techniques, they gained clues about the functions of uncharacterized proteins by mapping their interactions with known ones.

"In our first paper, we found about 2,000 interactions that we think are particularly robust, out of more than 100,000 total," he says. "These top 2 percent of interactions are really telling us something about protein function and will be very useful to the research community in the years ahead."

The studies already helped assign function to three previously unknown proteins. The first one plays a key role in the assembly of complex I, the first of a series of protein complexes used to create ATP. Complex I deficiencies represent the largest class of inborn errors of metabolism. The team revealed that complex I does not function when missing this protein.

"Patients with complex I deficiencies are unable to turn sugar and other sources of fuel into energy," says Brendan Floyd, a UW-Madison MD-PhD student and co-author. "They can't make ATP and complete other processes. Symptoms can be very wide-ranging, from severe inborn diseases that are fatal, to effects later in life related to the inability to grow properly or exercise."

Floyd says the team confirmed this finding by examining the case of a patient with a complex I disorder. That patient appeared to have a deficiency in the protein the team identified.

Two other newly defined proteins are players in the production and use of coenzyme Q, a molecule that is essential to energy production within all cells. Coenzyme Q has been called the "spark plug" of the cell since all fuels being broken down by mitochondria to produce ATP rely on its action.

Inborn coenzyme Q deficiencies can lead to brain and muscular disorders, and coenzyme Q can be in lower quantities in people with cancer, diabetes, heart conditions, Parkinson's and other diseases.

Floyd says the identification of protein function can be an essential first step in the eventual quest to develop therapies. Protein function discoveries in the past 20 years have been the impetus for therapies for cystic fibrosis, and the ability to inhibit certain types of protein expression is at the heart of cholesterol-lowering statin drugs.

The second paper identified a link between a protein used in coenzyme Q synthesis and the development of cerebellar ataxia, which leads to abnormalities in balance, gait and eye movement. An international collaboration with Hélène Puccio and colleagues in France was key for this work. The researchers found that this protein is required for assembling other coenzyme Q-related proteins into a complex inside mitochondria. By working with Craig Bingman, a protein crystallographer in the Department of Biochemistry at UW-Madison, the team also captured new snapshots of this protein in action.

Jonathan Stefely, a Morgridge postdoctoral research associate and co-author, says the research will continue for many more missing steps in the pathway that produces coenzyme Q. This molecule can only be produced in the body and does not come from diet. "If we know the biochemical functions of proteins throughout this pathway, we might be able to design therapies or drugs that bypass a dysfunctional step in coenzyme Q production," he says.

Pagliarini says these findings only scratch the surface of what useful information may be found in their protein interaction database, which is public and available to the research community. This initial project focused on 50 uncharacterized proteins that, based on literature searches, showed some likelihood of being associated with human disease. "We hope that researchers around the world will use our data to further understand how these mitochondrial protein work, thereby giving us a chance to fix them when they malfunction," says Pagliarini.
-end-


Morgridge Institute for Research

Related Cystic Fibrosis Articles:

Rare mutations drive cystic fibrosis in Caribbean
Cystic Fibrosis (CF) in the Caribbean is dominated by unusual gene mutations not often observed in previously studied CF populations, according to comprehensive genome sequencing led by physician-scientists at UC San Francisco and Centro de Neumología Pediátrica in San Juan.
Cystic fibrosis carriers at increased risk of digestive symptoms
Researchers have found that carriers of the most common genetic variant that causes cystic fibrosis experience some symptoms similar to those of people with cystic fibrosis.
In cystic fibrosis, lungs feed deadly bacteria
A steady supply of its favorite food helps a deadly bacterium thrive in the lungs of people with cystic fibrosis, according to a new study by Columbia researchers.
Cibio knocks out cystic fibrosis
The fight against cystic fibrosis continues, targeting in particular some of the mutations that cause it.
Hypertonic saline may help babies with cystic fibrosis breathe better
Babies with cystic fibrosis may breathe better by inhaling hypertonic saline, according to a randomized controlled trial conducted in Germany and published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Understanding antibiotic resistance in patients with cystic fibrosis
Patients with cystic fibrosis who carried antibiotic-resistant bacteria in their lungs had significantly lower microbial diversity and more aggressive disease, according to a small study published in Heliyon.
Research shows that cystic fibrosis impacts growth in the womb
New research, published in Thorax, funded by the Cystic Fibrosis Trust has shown that babies with cystic fibrosis (CF) are born weighing less than babies without the condition, even allowing that they are more likely to be born prematurely.
Discovery gives cystic fibrosis researchers new direction
A multi-disciplinary team of researchers at the Novartis Institutes for BioMedical Research (NIBR) and Harvard Medical School (HMS) started out trying to catalogue all the different cells in the airway and the paths they take to become those cells.
Supplemental antioxidants may reduce exacerbations in cystic fibrosis
An antioxidant-enriched vitamin may decrease respiratory exacerbations in people with cystic fibrosis (CF), according to new research published online in April in the American Journal of Respiratory and Critical Care Medicine.
Protein structure could unlock new treatments for cystic fibrosis
Biochemists at the University of Zurich have used cryo-electron microscopy to determine the detailed architecture of the chloride channel TMEM16A.
More Cystic Fibrosis News and Cystic Fibrosis Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab